标题：THE EFFECTS OF GINSENOSIDE Rg1 ON CHRONIC STRESS INDUCED DEPRESSION-LIKE BEHAVIORS, BDNF EXPRESSION AND THE PHOSPHORYLATION OF PKA AND CREB IN RATS
作者：Liu, Z.; Qi, Y.; Cheng, Z.; Zhu, X.; Fan, C.; Yu, S. Y.
作者机构：[Liu, Z.; Qi, Y.; Cheng, Z.; Zhu, X.; Fan, C.; Yu, S. Y.] Shandong Univ, Sch Med, Dept Physiol, Wenhuaxilu Rd, Jinan 250012, Shandong, Peoples R China 更多
通讯作者地址：[Yu, SY]Shandong Univ, Sch Med, Dept Physiol, Wenhuaxilu Rd, Jinan 250012, Shandong, Peoples R China.
关键词：ginsenoside Rg1; chronic unpredictable mild stress; depression; BDNF;; amygdala
摘要：Depression is a common neuropsychiatric disorder which has been associated with a wide range of structural and functional changes within specific brain regions. Ginsenoside Rg1 has been shown to exert a number of neuroprotective effects as demonstrated in various in vivo and in vitro studies. However, little information is available regarding the site and mechanisms of ginsenoside Rg1 in promoting antidepressant effects. The present study aimed to investigate the neuroprotective and ameliorating effects of ginsenoside Rg1 on depression-like behavior as induced by chronic unpredictable mild stress (CUMS). The results showed that CUMS was effective in producing depression-like behaviors in rats as indicated by decreased responses in sucrose preference and forced swim tests which were associated with ultrastructural changes in neurons within the amygdala. Moreover, levels of PKA and CREB phosphorylation and the expression of brain-derived neurotrophic factor (BDNF) were decreased in the amygdala of CUMS rats. Remarkably, chronic ginsenoside Rg1 (40 mg/kg, i.p., 5 weeks) treatment significantly ameliorated these behavioral and biochemical alterations associated with CUMS-induced depression. Taken together, the results of the present study demonstrate that ginsenoside Rg1 exhibits antidepressant-like effects against CUMS-induced depression. This amelioration of depression-like behaviors by ginsenoside Rg1 appears to be mediated, at least in part, by a CREB-regulated increase of BDNF expression in the amygdala of rats. Therefore, these findings reveal the therapeutic potential of ginsenoside Rg1 for use in clinical trials in the treatment of depression. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.